POSTER SESSION II
Monday, February 28, 2011 — 1:00 PM - 4:30 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
27
Cost-Benefit Analysis of Intraoperative Diagnosis of Axillary Sentinel Lymph Nodes in Breast Cancer Patients.
(240)
HT Richard, DL Johnson, CN Powers, MO Idowu - Virginia Commonwealth University, Richmond
Factors Influencing Accuracy of Sentinel Node Frozen Section for Breast Cancer: A Review of 654 Cases Including 1678 Sentinel Nodes.
(229)
D Pandya, M Singh, B O'Hea, P Farrelly, M Burk, C Rizk, C Tornos - Stony Brook University Medical Center, NY; Stony Brook University Medicfal Center, NY
Axillary Lymph Node Status in Breast Cancer by Frozen Section Diagnosis.
(267)
JA Thome, CF Mendiburu, FMC Palma, AR Moriel, AR Fett-Conte - Rio Preto Medical School,, Sao Jose do Rio Preto, Sao Paulo, Brazil; Institute of Pathology and Cytopathology, Sao Jose do Rio Preto, Sao Paulo, Brazil; Rio Preto Medical School, Sao Jose do Rio Preto, Sao Paulo, Brazil
The Method of Intraoperative Evaluation Does Not Affect the False Negative Rate of Sentinel Lymph Nodes in Breast Cancer Patients.
(241)
HT Richard, DL Johnson, CT Garrett, MO Idowu, CN Powers - Virginia Commonwealth University, Richmond
Preoperative Staging of the Axilla in Clinically Node Negative Breast Cancer Patients . The Memorial Sloan Kettering Sentinel and Non-Sentinel Nomograms and the University of Kentucky Approach Using Axillary Ultrasound and Fine Needle Aspiration Biopsy.
(166)
RA Hillard, Y Musgrave, H Wright, P Macgrath, E Romond, A Moore, LM Samayoa - University of Kentucky, Lexington; VAMC, Lexington; Instituto Internacional de Cancer, San Salvador, El Salvador
Outcomes of Breast Cancer Patients with Micrometastasis and Isolated Tumor Cells in Sentinel Lymph Nodes.
(159)
NC Gloyeske, W Goreal, M O'Neil, C Connor, OW Tawfik, F Fan - University of Kansas Medical Center, Kansas City
Problem: Equivocal Color of Ink on Lumpectomy Margins upon Microscopy. Solution: Naked Eye Assessment of the Margin on the Corresponding Tissue Block.
(168)
SA Hoda, L Cervino, JG Jones - Weill Cornell Medical College, New York, NY
Presence of Atypia in Breast Papillary Lesions in Core Biopsy: Does It Matter to the Clinician?
(214)
M Mashhour, A Shehata, L Alriyees, RS Saad - Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Incidence of Columnar Cell Lesions in the NSABP B-17 Lobular Neoplasia Patients, Using Digitized Images.
(115)
JW Byers, ML Cibull, S Kim, B Yolanda, LM Samayoa - University of Kentucky, Lexington; VAMC, Lexington, KY; Instituto Internacional de Cancer, San Salvador, El Salvador
Is Breast Excision Necessary When Flat Epithelial Atypia Is Diagnosed on Breast Core Biopsy?
(152)
A Faustin, C Annaiah, S Bose, F Dadmanesh - Cedars Sinai Medical Center, Los Angeles, CA
Trends and Histopathological Findings in Prophylactic Mastectomies: An 18 Year Retrospective Study.
(204)
AL Lo, B Singh - New York University Langone Medical Center, NY
Survival of Breast Intracystic/Solid Papillary Carcinoma Compared to Ductal Carcinoma In Situ.
(147)
L Elavathil, J Sussman, N Akhtar-Danesh, A Manan, A Lytwyn - Juravinski Hospital, Hamilton, ON, Canada; Juravinski Cancer Centre, Hamilton, ON, Canada; McMaster University, Hamilton, ON, Canada
Factors Associated with Presence/Absence of Residual Disease after Initial Breast-Conserving Surgery for Ductal Carcinoma In Situ (DCIS).
(282)
S Wei, C Kragel, O Hameed - University of Alabama at Birmingham
Impact of EZH2 and ALDH1 Expression on Ductal Carcinoma In Situ (DCIS) Recurrence.
(290)
AK Witkiewicz, J Kline, G Schwartz, K Toy, ME Gonzalez, CG Kleer - Thomas Jefferson University, Philadelphia, PA; University of Michigan, Ann Arbor
Epithelial and Myoepithelial Biomarkers Expression and Risk of Subsequent Loco-Regional Relapses after Conservative Treatment of Ductal Carcinomas In Situ.
(247)
A Rouquette, V Gobeaux, A Cedenot, D Hajage, N Gruel, S Alran, B Sigal-Zafrani, Y Kirova, A Fourquet, A Vincent-Salomon - Institut Curie, Paris, France
Co-Expression of p16 and p53 in the Spectrum of Ductal Intraepithelial Neoplasias.
(104)
CJ Bechert, JY Kim, FA Tavassoli - Yale University, New Haven, CT
Are Prognostic Factors the Same for Non-Invasive and Invasive Local Recurrence (LR) in Patients with Ductal Carcinoma In Situ (DCIS) Treated with Breast-Conserving Therapy (BCT)?
(131)
L Collins, N Achacoso, R Haque, L Nekhlyudov, S Fletcher, C Quesenberry, S Schnitt, L Habel - Beth Israel Deaconess Medical Center, Boston; Kaiser Permanente, California; Harvard Pilgrim Health Care Institute, Boston
Neuroendocrine Tumors (NETs) Account for 44% of Breast Cancers Detected by the Clinical Symptom of Bloody Nipple Discharge.
(190)
T Kawasaki, T Kondo, H Yamauchi, T Yamane, T Nakazawa, K Mochizuki, Y Ishii, H Yagata, H Tsunoda, S Nakamura, T Maruyama, A Inoue, M Inoue, S Inoue, K Kono, H Fujii, R Katoh - University of Yamanashi, Japan; St. Luke's International Hospital, Tokyo, Japan
Mammary Liposarcoma: A Clinicopathologic and Molecular Analysis.
(211)
PL Lyle, JF Simpson, JA Bridge, JM Cates, DL Page, ME Sanders - Vanderbilt University Medical Center, Nashville, TN; University of Nebraska, Omaha
Squamous Cell Carcinoma of the Breast: A Clinicopathologic Study of 21 Cases.
(225)
A Nayak, S Krishnamurthy, Y Wu, MZ Gilcrease - The University of Texas M.D. Anderson Cancer Center, Houston
Atypical Apocrine Adenosis of the Breast: Long Term Follow-Up in 37 Patients.
(155)
NE Fuehrer, LC Hartmann, TM Allers, RA Vierkant, MH Frost, DW Visscher - Mayo Clinic, Rochester, MN
Missed Malignancy in Benign Papillary Lesions of the Breast Diagnosed on Biopsy: Cases with Surgical Follow-Up.
(233)
S Petkiewicz, S Islam - The Ottawa Hospital, ON, Canada
Non-Atypical Papillary Lesions of the Breast Diagnosed on Core Biopsy: Follow-Up Surgical Excision of 110 Cases.
(287)
DT Wheeler, BL Strauss - QUEST Diagnostics, Las Vegas, NV
Pleomorphic Lobular Carcinoma: Immunohistochemistry Study of 27 Cases.
(218)
L Monhollen, C Morrison, F Ademuyiwa, R Chandrasekhar, G Wilding, T Khoury - Roswell Park Cancer Institute, Buffalo, NY
Invasive Pleomorphic Lobular Carcinoma: A Clinicopathologic and Immunohistochemistry Study of 40 Cases.
(217)
L Monhollen, C Morrison, F Ademuyiwa, R Chanddrasekhar, G Wilding, T Khoury - Roswell Park Cancer Institute, Buffalo, NY
Inter-Observer Variability by Breast Pathologists in the Distinction between Fibroadenomas with Increased Stromal Cellularity and Phyllodes Tumors.
(198)
TJ Lawton, G Acs, P Argani, G Farshid, M Gilcrease, N Goldstein, FC Koerner, J Rowe, M Sanders, C Reynolds - Seattle Breast Pathology Consultants, WA
Mucinous Variant of Invasive Micropapillary Carcinoma (MIMPC) of the Breast . Analysis of Clinicopathologic Features in Comparison with Pure Mucinous and Invasive Micropapillary Carcinoma (IMPC).
(93)
G Acs, NN Esposito, C Laronga - Ruffolo Hooper & Associates, Tampa, FL; Moffitt Cancer Center, Tampa, FL
Mucocele-Like Lesions in Needle Core Biopsies: Is Excision Always Necessary?
(139)
S Davion, K Siziopikou, M Feldman, EB Mendelson, M Sullivan - Northwestern University Feinberg School of Medicine, Chicago, IL
Carcinoma In Situ Involving Sclerosing Adenosis: Diagnostic Pearls To Aid the Practicing Pathologist.
(242)
D Richards, AA Ayala, LP Middleton - UT MD Anderson Cancer Center, Houston, TX; Methodist Hospital, Houston, TX
Minimally Invasive Paget Disease of Breast: An Under-Recognized Entity in the Breast.
(146)
X Duan, NE Sneige, AE Gullett, VG Prieto, E Resetkova, CT Albarracin - University of Texas Health Science Center, Houston; MD Anderson Cancer Center, Houston, TX
Idiopathic Granulomatous Mastitis a Rare Entity Often Masquerading as Carcinoma: Report of 6 Cases.
(177)
D Jaggessarsingh, PH Kane, C Bernstein, M Singh, P Farrelly, B O'Hea, C Tornos - Stony Brook University Medical Center, NY
Luminal A Breast Adenocarcinoma Has Similar Rate of Metastatic Progression as Luminal B but Greater Overall and Disease Free Survival.
(299)
R Zreik, C Chisholm, C Yao, C Ruud, VO Speights - Scott & White Memorial Hospital, Temple, TX
Pathways Up-Regulated in Basal-Like Breast Cancer.
(297)
M Zhong, L Gao, X Zhao, M Geller, F Ye, D Zhang, D Song - The Mount Sinai Medical Center, New York, NY; The First Hospital, Jilin University, Changchun, China
PTEN, Phospho-Akt and IGF-1 Receptor Expression in Triple Negative Breast Cancers: An Immunohistochemical Study with Outcome Correlation.
(265)
PHH Tan, AA Thike, PY Cheok - Singapore General Hospital, Singapore
Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of Response to Platinum Based Therapy for Women with Triple Negative Breast Cancer.
(128)
M Cioffi-Lavina, J Hurley, M Jorda, GR Walker, C Gomez-Fernandez - University of Miami Jackson Memorial Hospital, FL; University of Miami, FL; University of Miami Hospitals, FL; Sylvester Comprehensive Cancer Center, Miami, FL
Six1 Expression in Triple Negative Breast Carcinoma: Correlation with Prognostic Parameters and Outcome.
(264)
HC Sullivan, A Adams, GM Oprea, AJ Page, C Cynthia - Emory University School of Medicine, Atlanta, GA
EGFR Over-Expression, Genetic Heterogeneity and Mutation in Triple Negative Breast Carcinomas.
(106)
A Behdad, J Lopategui, S Bose - Cedar-Sinai Medical Center, Los Angeles, CA
Post Treatment High Ki67 Expression Level (>10%) Is Significantly Associated with Distant Metastasis in Triple-Negative Breast Carcinomas Treated with Neoadjuvant Chemotherapy Followed by Surgery.
(145)
L Duan, J Yan, V Sarode, R Rao, AM Leitch, D Euhus, D Cao, X-J Xie, Y Peng - University of Texas Southwestern Medical Center, Dallas; Washington University School of Medicine, St. Louis, MO
Molecular Subtypes of DCIS in African-American (AA) and Caucasian (CA) Women.
(253)
B Sharaf Aldeen, J Feng, H Nassar-Warzecha - Wayne State University/Detroit Medical Center, MI; Johns Hopkins Medical Institutions, Baltimore, MD
CUL4A, a Promising New Therapeutic Target for Triple Negative (Basal-Like) Breast Cancer Patients.
(255)
SJ Shin, L Lee, P Chadwick, YF Liu, S Monni, P Zhou - Weill Cornell Medical College, New York
Breast Cancer (BC) in Mexican Women Younger Than Age 45 Years. A Clinicopathologic (CP) Study of 1,320 Cases.
(97)
I Alvarado-Cabrero, R Valencia-Cedillo, S Barroso-Bravo - Mexican Oncology Hospital, Mexico, DF, Mexico
Is the CD44+/CD24-Phenotype a Biologically Significant Subgroup among Triple Negative Breast Cancers?
(185)
R Kaplan, L Lee, J Yan, Y-F Liu, P Chadwick, S Monni, SJ Shin - Weill Cornell Medical College, New York
Melatonin MT1 Receptor in Triple Negative Breast Carcinoma (TNBC) and Estrogen Receptor Positive Invasive Ductal Carcinoma (ER+DC).
(228)
GM Oprea-Ilies, E Haus, LL Sackett-Lundeen, H Sullivan, R Bush, A Adams, C Cohen - Emory University, Atlanta, GA; University of Minnesota, Minneapolis; Regions Hospital, St. Paul, MN
Difference in Melatonin Receptor (MT1) Expression in Triple Negative Breast Carcinoma (TNBC) between African American (AA) and Caucasian (CS) American Women.
(227)
GM Oprea-Ilies, E Haus, LL Sackett-Lundeen, A Adams, C Cohen - Emory University, Atlanta, GA; University of Minnesota, Minneapolis; Regions Hospital, St. Paul, MN
p53 Expression in Triple Negative Breast Carcinomas: Evidence of Racial and Age-Related Differences.
(140)
S Davion, M Sullivan, SM Rohan, KP Siziopikou - Northwestern University Feinberg School of Medicine, Chicago, IL
Yes-Associated Protein (YAP) Is Expressed in a Subset of Triple-Negative Breast Cancers.
(292)
S Yasir, R Tufail, C Gomez-Fernandez, Z Nawaz, P Pal, M Jorda - University of Miami, Jackson Memorial Hospital, FL; University of Miami, FL
Differential S100 Protein Family Expression in the Basal-Like Breast Carcinoma Subtype.
(257)
K Singh, S Lu, H Sidhu, L Noble, R Tavares, R DeLellis, M Resnick, E Yakirevich - Rhode Island Hospital/Alpert Medical School of Brown University, Providence
Differences in the Prevalence of Triple-Negative Breast Cancer and the Expression of Selected Tumor Markers in African American and Caucasian Breast Cancer Patients.
(174)
Y Hussein, S Bandyopadhyay, M Cote, B Albashiti, D Shi, A Almradi, Q Ahmed, R Ali-Fehmi - Wayne State University, Detroit, MI; Karmanos Cancer Institute, Detroit, MI
Membranous Expression of Activated Ezrin/Radixin/Moesin (ERM) Protein Is Positively Linked to Triple Negative Breast Cancer.
(271)
S Varma, A Day, J Cass, V Hoskin, B Sartova, H Mak, L Raptis, Y Madarnas, S Sengupta, B Elliott - Queen's University and Kingston General Hospital, Kingston, ON, Canada; Cancer Research Institute, Kingston, ON, Canada
button next to any title to add to Itinerary Planner...
Add
